Breaking News
Get 45% Off 0
Is it finally time to sell Nvidia ahead of earnings?
Read More

Stock Markets Analysis & Opinion

Contribute
Zacks Investment Research
Campbell's (CPB) Toronto Plant Closure To Boost Cost Savings By Zacks Investment Research - Jan 24, 2018

Campbell Soup Company (NYSE:CPB) has decided to wind down its manufacturing facility in Toronto and integrate the Canadian soup and broth production to its three existing factories in the United...

Zacks Investment Research
Scientific Games Posts Preliminary Q4 Results, Buys Tech Art By Zacks Investment Research - Jan 24, 2018

Scientific Games Corp (NASDAQ:SGMS) recently announced preliminary fourth-quarter and full-year 2017 results. The company also concluded the previously announced acquisition of Tech Art.The company...

Zacks Investment Research
Compass Diversified To Tap Wax Melts Market With New Buyout By Zacks Investment Research - Jan 24, 2018

Sterno Products, LLC, a subsidiary of Compass Diversified Holdings LLC (NYSE:CODI) , has recently announced its plans to acquire Rimports Inc., a leading manufacturer and distributor of wickless...

Zacks Investment Research
Pfizer's Rituxan Biosimilar Meets Endpoint In Phase III By Zacks Investment Research - Jan 24, 2018

Pfizer Inc. (NYSE:PFE) announced positive top-line results from a phase III comparative study, evaluating PF-05280586, the company’s biosimilar version of Roche's (OTC:RHHBY) blockbuster...

Zacks Investment Research
Top Ranked Momentum Stocks To Buy For January 25th By Zacks Investment Research - Jan 24, 2018

Here are four stocks with buy rank and strong momentum characteristics for investors to consider today, January 25th:E*TRADE Financial Corporation (ETFC): This financial services company has a Zacks...

Zacks Investment Research
EPA To Review Chevron's (CVX) Wheatstone Project Emission By Zacks Investment Research - Jan 24, 2018

Chevron Corporation (NYSE:CVX) is likely to face tighter emissions barriers at its Wheatstone LNG project, located in Western Australia, depending on the latest environmental inspection by the state...

Zacks Investment Research
Teradyne (TER) Beats Earnings And Revenue Estimates In Q4 By Zacks Investment Research - Jan 24, 2018

Teradyne Inc. (NYSE:TER) reported fourth-quarter 2017 earnings of 46 cents per share, surpassing the Zacks Consensus Estimate by 12 cents. Earnings decreased 15% sequentially but increased 44% year...

Zacks Investment Research
L3 Technologies (LLL) Q4 Earnings Top, Raises '18 EPS View By Zacks Investment Research - Jan 24, 2018

L3 Technologies, Inc. (NYSE:LLL) posted fourth-quarter 2017 adjusted earnings of $2.35 per share from continuing operations, surpassing the Zacks Consensus Estimate of $2.30 by 2.2%.The company...

Zacks Investment Research
Dr. Reddy's (RDY) Q3 Earnings Fall, Revenues Improve Y/Y By Zacks Investment Research - Jan 24, 2018

Dr. Reddy's Laboratories Ltd. (NYSE:RDY) reported third-quarter fiscal 2018 earnings per American Depositary Share (ADS) of 32 cents, down 27.3% from 44 cents earned in the year-ago quarter....

Zacks Investment Research
What's In Store For Boston Properties (BXP) In Q4 Earnings? By Zacks Investment Research - Jan 24, 2018

Boston Properties, Inc. (NYSE:BXP) is scheduled to report fourth quarter and 2017 results on Jan 30, after the market closes.Last quarter, this REIT, which mainly owns and develops Class A office...

Zacks Investment Research
Shire Gets FDA Nod For Cinryze Tech Transfer To New Site By Zacks Investment Research - Jan 24, 2018

Shire plc (NASDAQ:SHPG) announced that it has received an FDA approval for transferring the product manufacturing technology of its hereditary angioedema (HAE) drug, Cinryze (C1 esterase inhibitor),...

Continue with Apple
Continue with Google
or
Sign up with Email